MetaCap

Armata Pharmaceuticals (ARMP) vs Voyager Therapeutics (VYGR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Armata Pharmaceuticals (ARMP) has outperformed Voyager Therapeutics (VYGR) over the past year, losing 56.9% versus a loss of 63.4%. Over five years, ARMP leads with a -42.0% price change compared with -50.0% for VYGR. Armata Pharmaceuticals is the larger company by market cap ($112.7 million vs $95.2 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARMP-56.90%VYGR-63.40%
+119%+23%-72%
Nov 21, 20251 yearNov 20, 2026
ARMP-22.70%VYGR-53.50%
+319%+112%-94%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARMP versus VYGR key metrics
MetricARMPVYGR
Share price$3.03$1.53
Market cap$112.69M$95.21M
1-day change+1.68%-4.97%
YTD return-51.75%-61.07%
1-year return-56.90%-63.40%
5-year return-41.95%-50.00%
EPS (TTM)$-4.17$-1.74
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$40.37M
Revenue growth (YoY)—-49.53%
Net income (latest FY)$-173.80M$-119.72M
Operating margin—-326.56%
Net margin—-296.53%
52-week high$14.98$5.48
52-week low$2.40$1.48
Distance from 52-week high-79.77%-72.08%
Analyst consensusnonestrong_buy
Avg. price target upside+477.56%+829.41%
Average volume182.52K770.24K
Shares outstanding37.19M62.23M
Employees61141
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Armata Pharmaceuticals

ARMP stock →

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 61 employees

About Voyager Therapeutics

VYGR stock →

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 141 employees

ARMP vs VYGR FAQ

Which is bigger, Armata Pharmaceuticals or Voyager Therapeutics?

Armata Pharmaceuticals (ARMP) is larger, with a market capitalization of $112.69M compared with $95.21M for Voyager Therapeutics (VYGR).

Which stock has performed better over the past year, ARMP or VYGR?

ARMP returned -56.90% over the past 12 months, compared with -63.40% for VYGR (price return, excluding dividends). Past performance does not predict future results.

Are Armata Pharmaceuticals and Voyager Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons